Ethyl N-carbamimidoyl-N-methylglycinate

Catalog No.: 
ACHCRM998
CAS No.: 
15366-29-7
Molecular Formula: 
C6H13N3O2
Molecular Weight: 
159.19
Ethyl N-carbamimidoyl-N-methylglycinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl N-carbamimidoyl-N-methylglycinate
IUPAC Nameethyl N-carbamimidoyl-N-methylglycinate
Molecular FormulaC6H13N3O2
Molecular Weight159.19
SMILESO=C(OCC)CN(C(N)=N)C
InChI KeyUFUWQSYRGLMLKP-UHFFFAOYSA-N
SynonymGlycine, N-(aMinoiMinoMethyl)-N-Methyl-, ethyl ester
CAS No.15366-29-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHCRM998 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJGDF154 route compound structure diagram
    ACJGDF15452605-49-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHCRM998 route product structure diagram
    ACHCRM99815366-29-7
Inquiry

2. ACHCRM998 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBOXP417 route compound structure diagram
    ACBOXP41721770-81-0In Stock
  4. Then
  5. ACHCRM998 route product structure diagram
    ACHCRM99815366-29-7
Inquiry

3. ACHCRM998 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACCKXR028 route compound structure diagram
    ACCKXR02871519-72-7In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACHCRM998 route product structure diagram
    ACHCRM99815366-29-7
Inquiry

Comments (0)